Omega Therapeutics Inc [NASDAQ: OMGA] price surged by 11.23 percent to reach at $0.05.
The one-year OMGA stock forecast points to a potential upside of 87.75. The average equity rating for OMGA stock is currently 2.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Omega Therapeutics Inc [OMGA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OMGA shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OMGA stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Raymond James have made an estimate for Omega Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on November 15, 2024. While these analysts kept the previous recommendation, Raymond James raised their target price to Outperform. The new note on the price target was released on June 18, 2024, representing the official price target for Omega Therapeutics Inc stock. Previously, the target price had yet another drop from $18 to $15, while Jefferies kept a Buy rating on OMGA stock.
The Average True Range (ATR) for Omega Therapeutics Inc is set at 0.09, with the Price to Sales ratio for OMGA stock in the period of the last 12 months amounting to 3.37. The Price to Book ratio for the last quarter was 2.36, with the Price to Cash per share for the same quarter was set at 0.55.
OMGA Stock Performance Analysis:
Omega Therapeutics Inc [OMGA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.38. With this latest performance, OMGA shares dropped by -40.75% in over the last four-week period, additionally sinking by -74.32% over the last 6 months – not to mention a drop of -87.09% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OMGA stock in for the last two-week period is set at 33.68, with the RSI for the last a single of trading hit 33.93, and the three-weeks RSI is set at 34.93 for Omega Therapeutics Inc [OMGA]. The present Moving Average for the last 50 days of trading for this stock 0.7890, while it was recorded at 0.4794 for the last single week of trading, and 1.5033 for the last 200 days.
Insight into Omega Therapeutics Inc Fundamentals:
Omega Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.61 and a Current Ratio set at 1.61.
Omega Therapeutics Inc [OMGA] Institutonal Ownership Details
There are presently around $90.43%, or 91.92%% of OMGA stock, in the hands of institutional investors. The top three institutional holders of OMGA stocks are: FLAGSHIP PIONEERING INC. with ownership of 29.23 million shares, which is approximately 52.9924%. FMR LLC, holding 6.24 million shares of the stock with an approximate value of $$12.92 million in OMGA stocks shares; and FMR LLC, currently with $$7.27 million in OMGA stock with ownership which is approximately 6.3682%.
